NO960016L - New acylated pseudopeptides with trifluoromethyl substituted 2-azabicyclooctane - Google Patents
New acylated pseudopeptides with trifluoromethyl substituted 2-azabicyclooctaneInfo
- Publication number
- NO960016L NO960016L NO960016A NO960016A NO960016L NO 960016 L NO960016 L NO 960016L NO 960016 A NO960016 A NO 960016A NO 960016 A NO960016 A NO 960016A NO 960016 L NO960016 L NO 960016L
- Authority
- NO
- Norway
- Prior art keywords
- carbon atoms
- straight chain
- stands
- different
- branched
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06139—Dipeptides with the first amino acid being heterocyclic
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/52—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring condensed with a ring other than six-membered
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06191—Dipeptides containing heteroatoms different from O, S, or N
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Virology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Biochemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- AIDS & HIV (AREA)
- Tropical Medicine & Parasitology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
Det blir beskrevet nye acylerte pseudopeptider med trifluormetyl-substituerte 2-azabicyklo-oktan med den generelle formel (I) hvor R1 står for en rest med formel eller N. ;x hvor A, D, E, L og T er Ilke eller forskjellige og står for hydrogen, halogen, rettkjedet eller forgrenet alkyl ned opptil 4 karbonatoner, morfollnyl, fenyltlo eller cykloalkyl med 3 til 6 karbonatomer, R2 står for rettkjedet eller forgrenet acyl ned opptil 20 karbonatomer, som eventuelt er substituert med karboksy, med rettkjedet eller forgrenet alkoksykar- bonyl ned opptil 6 karbonatomer eller med en gruppe med formelen -KR3R4, hvor . R3 og 'R4 er like eller forskjellige og «tar for hydrogen, fenyl eller rettkjedet eller forgrenet alkyl ned opptil 6 karbonatomer, står for en rest med formelen -CO-XR5R6 eller P(0)(OR7)(OR8), hvor R8 og R6 har den ovenfor angitte betydning for R3 og R4 og er Ilke eller forskjellige, R7 og R8 er Ilke eller forskjellige og står for hydrogen eller rettkjedet eller forgrenet alkyl med opptil 4 karbonatomer, eller står for rettkjedet eller forgrenet alkoksy med opptil 6 karbonatomer, som eventuelt er substituert med dlfluormetyl, dlfluormetoksy, trlfluonnetoksy eller trlfluormetyl, eller for en rest med formlene HA c", ^° Hf og deres salter.New acylated pseudopeptides of trifluoromethyl-substituted 2-azabicyclooctane of general formula (I) are disclosed wherein R 1 represents a residue of formula or N. x where A, D, E, L and T are Ilke or different and stands for hydrogen, halogen, straight chain or branched alkyl down to 4 carbon atoms, morpholyl, phenylthlo or cycloalkyl having 3 to 6 carbon atoms, R2 stands for straight chain or branched acyl down to 20 carbon atoms optionally substituted by carboxy, straight chain or branched alkox - bonyl down to 6 carbon atoms or with a group of the formula -KR3R4, where. R 3 and 'R 4 are the same or different and' takes for hydrogen, phenyl or straight chain or branched alkyl down to 6 carbon atoms, represents a residue of the formula -CO-XR 5 R 6 or P (O) (OR 7) (OR 8), where R 8 and R6 is as defined above for R3 and R4 and is Ilk or different, R7 and R8 are Ilk or different and stands for hydrogen or straight chain or branched alkyl of up to 4 carbon atoms, or stands for straight chain or branched alkoxy of up to 6 carbon atoms, which is optionally substituted with difluoromethyl, difluoromethoxy, trifluoromethoxy or trifluoromethyl, or for a residue of the formulas HA c "," Hf and their salts.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE19500120A DE19500120A1 (en) | 1995-01-04 | 1995-01-04 | New acylated pseudopeptides with trifluoromethyl-substituted 2-azabicyclooctane |
Publications (2)
Publication Number | Publication Date |
---|---|
NO960016D0 NO960016D0 (en) | 1996-01-03 |
NO960016L true NO960016L (en) | 1996-07-05 |
Family
ID=7750986
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO960016A NO960016L (en) | 1995-01-04 | 1996-01-03 | New acylated pseudopeptides with trifluoromethyl substituted 2-azabicyclooctane |
Country Status (15)
Country | Link |
---|---|
EP (1) | EP0720987A1 (en) |
JP (1) | JPH08259594A (en) |
KR (1) | KR960029345A (en) |
CN (1) | CN1134940A (en) |
AU (1) | AU4067895A (en) |
CA (1) | CA2166374A1 (en) |
CZ (1) | CZ1296A3 (en) |
DE (1) | DE19500120A1 (en) |
FI (1) | FI960015A (en) |
HU (1) | HUT74805A (en) |
IL (1) | IL116622A0 (en) |
NO (1) | NO960016L (en) |
NZ (1) | NZ280729A (en) |
PL (1) | PL312146A1 (en) |
SK (1) | SK1296A3 (en) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
PE20001420A1 (en) * | 1998-12-23 | 2000-12-18 | Pfizer | CCR5 MODULATORS |
US6448245B1 (en) | 2000-05-04 | 2002-09-10 | The United States Of America As Represented By The Department Of Health And Human Services | Methods of and compounds for inhibiting calpains |
AU2004298486A1 (en) | 2003-12-12 | 2005-06-30 | Wyeth | Quinolines useful in treating cardiovascular disease |
JP4831410B2 (en) | 2006-02-28 | 2011-12-07 | 東亞合成株式会社 | Antiviral peptides and antiviral agents |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB1408675A (en) | 1973-03-16 | 1975-10-01 | Allen & Hanburys Ltd | Amides derived from quinoxaline |
CA1340588C (en) * | 1988-06-13 | 1999-06-08 | Balraj Krishan Handa | Amino acid derivatives |
DE4126485A1 (en) | 1991-08-10 | 1993-02-11 | Bayer Ag | TRIFLUOROMETHYL-CONTAINING PSEUDOPEPTIDE |
TW372972B (en) | 1992-10-23 | 1999-11-01 | Novartis Ag | Antiretroviral acyl compounds |
-
1995
- 1995-01-04 DE DE19500120A patent/DE19500120A1/en not_active Withdrawn
- 1995-01-04 SK SK12-96A patent/SK1296A3/en unknown
- 1995-12-21 NZ NZ280729A patent/NZ280729A/en unknown
- 1995-12-22 EP EP95120369A patent/EP0720987A1/en not_active Withdrawn
- 1995-12-27 JP JP7351205A patent/JPH08259594A/en active Pending
- 1995-12-28 AU AU40678/95A patent/AU4067895A/en not_active Abandoned
- 1995-12-29 HU HU9503927A patent/HUT74805A/en unknown
- 1995-12-29 IL IL11662295A patent/IL116622A0/en unknown
- 1995-12-29 CA CA002166374A patent/CA2166374A1/en not_active Abandoned
-
1996
- 1996-01-02 PL PL96312146A patent/PL312146A1/en unknown
- 1996-01-02 FI FI960015A patent/FI960015A/en unknown
- 1996-01-03 KR KR1019960000008A patent/KR960029345A/en not_active Application Discontinuation
- 1996-01-03 NO NO960016A patent/NO960016L/en unknown
- 1996-01-03 CZ CZ9612A patent/CZ1296A3/en unknown
- 1996-01-04 CN CN96100927A patent/CN1134940A/en active Pending
Also Published As
Publication number | Publication date |
---|---|
DE19500120A1 (en) | 1996-07-11 |
HU9503927D0 (en) | 1996-03-28 |
SK1296A3 (en) | 1996-08-07 |
KR960029345A (en) | 1996-08-17 |
JPH08259594A (en) | 1996-10-08 |
CA2166374A1 (en) | 1996-07-05 |
NZ280729A (en) | 1996-08-27 |
NO960016D0 (en) | 1996-01-03 |
PL312146A1 (en) | 1996-07-08 |
FI960015A0 (en) | 1996-01-02 |
FI960015A (en) | 1996-07-05 |
CZ1296A3 (en) | 1997-05-14 |
AU4067895A (en) | 1996-07-11 |
IL116622A0 (en) | 1996-03-31 |
CN1134940A (en) | 1996-11-06 |
HUT74805A (en) | 1997-02-28 |
EP0720987A1 (en) | 1996-07-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NZ240676A (en) | Heterocyclic compounds substituted by a (piperidin-4-yl)-1-oxoalkyl group and pharmaceutical compositions thereof | |
RS20050081A (en) | Pyrazole derivatives and process for the production thereof | |
HUP0002057A2 (en) | Indazole amide compounds, process for producing them, pharmaceutical compositions containing them and their intermediers | |
IL164487A0 (en) | 3-Heteroaryl substituted 5-methyloxymethyl isoxazolines used as herbicides | |
DK1008592T3 (en) | Cyclic amide derivatives which inhibit cathepsin K | |
DE602005005167D1 (en) | 1-ISOPROPYL-2-OXO-1,2-DIHYDROPYRIDINE-3-CARBOXYLIC ACID AMID DERIVATIVES WITH AGONISTIC ACTIVITY AT THE 5-HT4 RECEPTOR | |
NO965305L (en) | New compounds, methods of their preparation and anti-tumor agents | |
NO20071008L (en) | Process for the preparation of N-piperidino-1,5-diphenylpyrazole-3-carboxamide derivatives | |
DE3876813D1 (en) | 3 (2H) PYRIDAZINONE, METHOD FOR THE PRODUCTION THEREOF AND ITS CONTAINER AGAINST SRS-A. | |
ES2157214T3 (en) | PROCEDURE TO PRODUCE DERIVATIVES OF AZETIDINONE SUBSTITUTED IN POSITION 4. | |
DE69918695D1 (en) | OXYGEN HETEROCYCLIC COMPOUNDS | |
NZ318843A (en) | Processes and intermediates for preparing 1-benzyl-4-((5,6-dimethoxy-1-indanon)-2-yl)methylpiperidine | |
MXPA05013631A (en) | Heterocyclic methyl sulfone derivative. | |
MX2010010471A (en) | Novel tetrahydroisoquinoline derivative. | |
NO960016L (en) | New acylated pseudopeptides with trifluoromethyl substituted 2-azabicyclooctane | |
CA2357038A1 (en) | Medical compositions comprising 1,4-benzothiazepine derivatives for the treatment of atrial fibrillation | |
NO971687D0 (en) | Diazepinoindoles as phosphodiesterase IV inhibitors | |
EP0995744A4 (en) | Cis-substituted fluoromethylpyrrolidine derivatives | |
DK1036793T3 (en) | Process for Preparation of 2-alkyl-3-aminothiophene derivative and 3-aminothiophene derivative | |
AR019197A1 (en) | COMPOSITES DERIVED FROM PIPERIDINE ANTIHISTAMINICS, INTERMEDIATE COMPOUNDS, PROCEDURE FOR PREPARATION OF PIPERIDINE DERIVATIVES AND PROCEDURES FOR THE PREPARATION OF INTERMEDIARIES. | |
NO20006350L (en) | Derivatives of 3- (2-oxo- [1,3 '] bipyrrolidinyl-3-ylidene methyl) cephemer | |
HUP0203315A2 (en) | Process and intermediates for the preparation of isoxazolecaroxamides and analogues | |
MY134226A (en) | 1,2-dihydropyrazol-3-ones which control inflammatory cyctokines | |
DE60000978D1 (en) | 22R-HYDROXYCHOLESTA-8,14-DIENE DERIVATIVES FOR INHIBITING MEIOSE | |
HUP0201863A2 (en) | Novel morpholine derivatives, method for the production thereof and pharmaceutical preparations containing the same |